BRANMOOR
THURSDAY ยท 14 MAY 2026

FDA Recall D-0607-2025

Boothwyn Pharmacy LLC · Kennett Square, PA

Class III Ongoing 309 days on record

Lower impact — Class III recall โ€” product violates FDA labeling or manufacturing standards but is unlikely to cause adverse health consequences.

Product

Fluorescein 2% Ophth, 3 ML, Boothwyn Pharmacy, 800-476-7496

Lot / code: 06092025@23 BUD 09/09/2025

Quantity: 8 vials

Reason for recall

Subpotent Drug

Recall record

Recall number
D-0607-2025
Classification
Class III
Status
Ongoing
Voluntary or mandated
Voluntary: Firm initiated
Firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Distribution
U.S. Nationwide
Recall initiated
2025-07-09
Classified by FDA Center
2025-08-29
FDA published
2025-09-10
Recalling firm
Boothwyn Pharmacy LLC
Firm location
Kennett Square, PA

Operational response

Class III recalls are unlikely to cause adverse health consequences but indicate a violation of FDA labeling or manufacturing standards. Pull from active dispensing per your operational policy.

For the official FDA enforcement record, see FDA's Recall Search.

‹ All recalls